IL2 and colon adenocarcinoma: Similarly, in murine colon adenocarcinoma models, IL-2 liposomes combined with T-activated killer cells enhanced the infiltration of Lyt-2+ lymphocytes into hepatic metastases, resulting in potent antitumor effects [156].